≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Infections specific to the perinatal period

EFO Endpoint Browser PheWeb

P16_INFECTIONS_SPECIFIC_PERINA_PERIOD

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — P35-P39
  • Cause of death: ICD-10 — P35-P39

2 out of 7 registries used, show all original rules.

436

4. Check minimum number of events

None

436

5. Include endpoints

436

6. Filter based on genotype QC (FinnGen only)

436

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
2
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
P
Name in latin
Infectiones temporis perinatalis specificae

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 42413 17614 24798
Only index persons 19844 8095 11749
Unadjusted period prevalence (%)
Whole population 0.61 0.50 0.69
Only index persons 0.39 0.30 0.45
Median age at first event (years)
Whole population 0.00 0.00 0.00
Only index persons 0.00 0.00 0.00

-FinnGen-

Key figures

All Female Male
Number of individuals 436 246 190
Unadjusted period prevalence (%) 0.08 0.08 0.08
Median age at first event (years) 0.00 0.00 0.00

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
383
Matched controls
3828
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
P39.9
ICD-10 Finland
Infection specific to the perinatal period, unspecified
+∞
157.5
140
*
P36.90
ICD-10 Finland
Suspected bacterial sepsis of newborn
+∞
144.1
129
*
P39.1
ICD-10 Finland
Neonatal conjunctivitis and dacryocystitis
+∞
23.2
22
*
P36.0
ICD-10 Finland
Sepsis of newborn due to streptococcus, group B
+∞
21.0
20
*
P36.99
ICD-10 Finland
Bacterial sepsis of newborn, unspecified
+∞
20.0
19
*
Z87.6
ICD-10 Finland
Personal history of certain conditions arising in the perinatal period
5.1
19.0
63
142
P01.10
ICD-10 Finland
Fetus and newborn affected by premature rupture of membranes 1-7 days before delivery
21.3
18.0
26
13
P22.1
ICD-10 Finland
Transient tachypnoea of newborn
7.6
15.0
35
50
P07.3
ICD-10 Finland
Other preterm infants
4.5
14.5
53
132
P39.4
ICD-10 Finland
Neonatal skin infection
+∞
11.5
11
*
P36.3
ICD-10 Finland
Sepsis of newborn due to other and unspecified staphylococci
+∞
10.5
10
*
P22.0
ICD-10 Finland
Respiratory distress syndrome of newborn
9.5
10.1
20
22
P39.0
ICD-10 Finland
Neonatal infective mastitis
+∞
9.4
9
*
P02.7
ICD-10 Finland
Fetus and newborn affected by chorioamnionitis
+∞
9.4
9
*
P22.9
ICD-10 Finland
Respiratory distress of newborn, unspecified
6.0
7.0
18
31
P21.1
ICD-10 Finland
Mild and moderate birth asphyxia
7.6
6.5
14
19
P38
ICD-10 Finland
Omphalitis of newborn with or without mild haemorrhage
71.0
6.4
7
*
ZX198
NOMESCO Finland
Other local administration
9.5
6.3
12
13
P59.0
ICD-10 Finland
Neonatal jaundice associated with preterm delivery
4.7
6.1
19
42

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3023368) Bacteria identified in Blood by Culture
80
504
1.72
4.30
5.0
4.2
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
18
65
2.84
3.90
3.4
4.4
umol/l
32.3
22.3
1.06
18
65
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
8
20
4.05
2.58
1.1
1.2
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
8
20
4.05
2.58
1.1
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
6
13
4.66
2.27
1.0
1.1
—
—
—
0
0
(3020891) Body temperature
14
60
2.38
2.24
3.5
7.8
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
5
9
5.60
2.22
1.0
1.0
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
47
308
1.59
2.19
2.4
2.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
8
24
3.37
2.19
1.3
1.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
47
309
1.58
2.17
2.2
2.0
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
7
19
3.72
2.16
1.0
1.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
31
184
1.74
2.10
5.2
5.9
%
0.0
0.0
—
10
52
(3001186) Copper [Moles/volume] in Serum or Plasma
6
15
4.04
2.04
1.2
1.2
umol/l
17.6
18.4
—
6
15
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
360
3362
1.41
1.96
12.1
10.3
mg/l
22.6
22.7
0.01
244
2237
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
51
0.00
1.90
0.0
1.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
17
86
2.02
1.87
19.8
14.0
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
32
199
1.66
1.86
5.4
5.8
%
0.6
0.5
—
10
66
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
6
17
3.56
1.84
1.2
1.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
6
17
3.56
1.84
1.2
1.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
6
17
3.56
1.84
1.2
1.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
56
398
1.47
1.83
2.4
2.0
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
8
29
2.79
1.80
1.0
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
17
88
1.97
1.77
1.5
2.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
21
118
1.82
1.73
2.3
2.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
8
30
2.70
1.73
1.3
2.4
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
8
30
2.70
1.73
1.1
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
10
42
2.41
1.68
1.2
1.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
10
42
2.41
1.68
1.1
1.0
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
81
625
1.36
1.68
3.4
3.7
e6/l
4.1
3.6
0.11
41
353
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
134
1113
1.29
1.67
4.4
4.5
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
6
19
3.19
1.66
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
6
19
3.19
1.66
1.0
1.0
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
29
182
1.64
1.65
5.6
5.2
%
0.7
0.4
—
9
46
(3023419) Bacteria identified in Sputum by Culture
5
14
3.60
1.62
2.2
22.8
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
54
392
1.43
1.60
1.7
1.4
nmol/l
17.1
18.7
0.51
45
343
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
6
20
3.03
1.58
2.2
1.6
pg
32.3
31.5
—
6
20
(3009214) Lutropin [Units/volume] in Serum or Plasma
42
291
1.49
1.57
2.1
2.4
u/l
6.6
5.4
0.69
30
188
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
169
1456
1.26
1.55
13.5
11.8
mmol/l
1.2
1.2
0.06
161
1387
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
110
900
1.30
1.53
2.9
3.1
—
—
—
0
0
(4010399)
28
179
1.60
1.49
1.6
1.5
—
—
—
0
0
(3018418) pH of Serum or Plasma
81
637
1.33
1.49
4.7
4.1
ph
7.4
7.4
—
10
114
(3029937) Albumin [Presence] in Urine by Test strip
81
637
1.33
1.49
3.1
3.5
estimate
0.0
0.0
0.00
30
231
(3019230) Fractional oxyhemoglobin in Venous blood
15
80
1.91
1.46
15.9
16.1
%
72.4
70.8
0.15
15
80
(3035350) Ketones [Presence] in Urine by Test strip
154
1322
1.25
1.44
3.4
3.3
estimate
0.0
0.0
0.00
27
228
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
6
22
2.75
1.44
1.3
1.0
—
—
—
0
0
(3000492) Spirometry study
35
240
1.50
1.39
1.6
1.4
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
153
1317
1.25
1.39
5.1
4.8
estimate
0.0
0.0
0.00
29
240
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
6
23
2.63
1.37
1.3
1.1
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
6
23
2.63
1.37
1.2
1.2
nmol/l
0.4
0.4
—
6
23
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
5
17
2.96
1.36
1.0
1.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
29
192
1.55
1.35
5.5
5.9
%
0.0
0.0
—
10
61
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
174
1524
1.24
1.35
12.7
11.1
mmol/l
1.2
1.2
0.49
160
1393
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
10
47
2.15
1.34
2.1
1.7
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
25
161
1.59
1.31
3.6
4.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
153
1326
1.24
1.30
3.5
3.4
estimate
0.0
0.0
0.00
30
235
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
78
623
1.31
1.30
3.5
3.6
e6/l
0.4
0.9
1.92
37
352
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
20
122
1.67
1.29
2.4
2.3
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
316
2955
1.25
1.29
15.2
11.6
mmol/l
3.9
3.9
0.07
309
2845
(3021589) Normoblasts [#/volume] in Blood
212
1902
1.22
1.29
9.2
10.6
e9/l
0.0
0.0
0.48
164
1444
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
123
1042
1.25
1.28
7.2
7.7
umol/l
19.5
20.0
0.05
110
946
(3030467) Casts [#/volume] in Urine by Automated count
118
997
1.25
1.25
4.2
4.2
e6/l
0.3
0.2
0.20
82
754
(3010015) Selenium [Moles/volume] in Serum or Plasma
6
25
2.42
1.24
1.5
3.0
umol/l
1.0
1.1
—
6
25
(3020630) Protein [Mass/volume] in Serum or Plasma
18
108
1.69
1.24
1.3
3.7
g/l
63.7
63.7
0.01
18
100
(3002256) Pathology report gross observation
31
214
1.48
1.22
1.0
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
90
741
1.27
1.19
3.3
3.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
16
94
1.73
1.19
1.3
2.1
—
—
—
0
0
(40761535) Cells panel - Urine sediment
21
134
1.60
1.16
3.6
3.9
—
—
—
0
0
(3004593) Baker's yeast IgA Ab [Units/volume] in Serum
0
34
0.00
1.16
0.0
1.2
—
33.4
—
0
9
(3008092) Baker's yeast IgG Ab [Units/volume] in Serum
0
34
0.00
1.16
0.0
1.2
—
18.5
—
0
10
(3000991) Gas panel - Venous blood
83
679
1.27
1.16
8.6
10.7
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
32
225
1.46
1.16
2.7
3.6
—
—
—
0
0
(4034850)
8
39
2.07
1.15
6.6
8.5
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
5
20
2.52
1.15
1.0
1.2
—
—
—
0
0
(44790047)
16
95
1.71
1.15
2.6
2.2
—
—
—
0
0
(44790049)
16
95
1.71
1.15
2.6
2.2
—
—
—
0
0
(44806118)
16
95
1.71
1.15
2.6
2.2
—
—
—
0
0
(44790048)
16
95
1.71
1.15
2.6
2.2
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
91
757
1.25
1.11
3.7
2.6
mmol/l
2.4
2.4
0.40
79
694
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
7
31
2.28
1.10
1.0
1.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
76
619
1.28
1.10
9.1
9.0
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
173
1540
1.20
1.10
8.3
9.2
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
12
66
1.84
1.10
1.8
1.6
iu/l
4.0
5.0
—
6
23
(3002582) Erythrocytes [#/volume] in Urine
123
1059
1.22
1.10
4.4
4.4
e6/l
25.2
22.1
0.11
87
813
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
5
21
2.40
1.09
1.0
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
5
21
2.40
1.09
1.2
1.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
21
2.40
1.09
1.2
1.2
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
5
21
2.40
1.09
1.0
1.2
—
—
—
0
0
(3015736) pH of Urine
124
1069
1.22
1.09
3.4
3.1
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
7
32
2.21
1.08
1.0
1.3
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
6
121
0.49
1.07
1.2
1.1
—
7.1
—
0
20
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
7
33
2.14
1.06
1.1
1.5
—
—
—
0
0
(40768441) Liver Pathology biopsy report
7
33
2.14
1.06
2.0
2.0
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
197
1780
1.19
1.05
6.9
5.4
u/l
125.6
120.6
0.34
181
1664
(3000494) Fungus identified in Specimen by Culture
37
273
1.39
1.05
1.6
2.1
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
314
2961
1.22
1.04
15.2
11.6
mmol/l
139.4
139.5
0.18
307
2870
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
104
885
1.23
1.03
3.0
3.4
mg/l
2.6
2.7
0.27
94
790
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
5
22
2.29
1.03
1.0
1.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
22
2.29
1.03
1.0
1.2
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
5
22
2.29
1.03
1.0
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
7
34
2.07
1.03
1.1
1.0
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
117
1009
1.22
1.02
4.2
4.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
9
157
0.56
1.00
1.1
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
62
499
1.28
0.99
1.8
1.7
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
34
250
1.39
0.99
2.2
2.0
u/ml
207.8
169.4
0.31
16
110
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
40
303
1.35
0.98
1.3
1.3
iu/ml
306.8
136.5
—
8
93
(3041672) Baker's yeast Ab [Presence] in Serum
0
30
0.00
0.97
0.0
1.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
78
649
1.25
0.96
2.8
2.9
kg/l
1.0
1.0
1.99
17
106
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
14
85
1.67
0.95
2.3
1.8
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
16
102
1.59
0.91
4.8
5.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
34
254
1.37
0.91
2.2
2.0
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
59
478
1.27
0.91
1.9
1.6
—
—
—
0
0
(4268621)
6
29
2.08
0.89
2.0
2.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
6
29
2.08
0.89
1.0
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
8
42
1.92
0.89
1.3
1.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
10
56
1.80
0.88
1.1
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
10
56
1.80
0.88
2.2
2.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
78
657
1.23
0.86
2.9
2.9
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
21
145
1.47
0.86
1.8
1.8
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
8
44
1.83
0.86
1.0
1.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
95
1095
0.83
0.86
5.3
4.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
138
1538
0.85
0.85
1.7
1.8
u/ml
0.8
3.2
2.80
23
287
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
322
3068
1.19
0.84
8.9
8.3
u/l
26.1
24.2
0.79
308
2958
(4035726)
23
163
1.43
0.83
1.8
1.7
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
59
484
1.25
0.83
4.1
4.9
mg/l
5.4
1.3
0.52
38
337
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
16
105
1.54
0.82
2.4
1.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
14
89
1.59
0.82
1.2
3.8
—
—
—
0
0
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
8
47
1.71
0.81
6.0
8.8
mg/l
2.7
2.4
—
8
37
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
83
709
1.21
0.81
11.2
9.0
mmol/l
1.0
1.0
0.08
60
494
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
24
0.00
0.79
0.0
2.5
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
0
24
0.00
0.79
0.0
3.7
—
230.3
—
0
14
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
6
33
1.83
0.79
1.2
1.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
19
268
0.70
0.79
1.2
1.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
8
48
1.68
0.79
1.9
1.7
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
20
140
1.45
0.78
3.7
2.3
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
16
107
1.51
0.77
4.7
4.9
mmol/l
3.5
3.3
0.59
16
102
(3024731) MCV [Entitic volume]
396
3859
1.29
0.77
18.0
14.8
fl
86.2
86.0
0.18
390
3781
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
34
1.77
0.76
2.0
1.2
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
34
1.77
0.76
9.3
7.9
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
28
0.00
0.76
0.0
1.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
5
24
2.09
0.74
1.2
2.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
5
24
2.09
0.74
1.0
1.1
—
—
—
0
0
(3035941) MCH [Entitic mass]
396
3861
1.28
0.74
18.0
14.8
pg
28.9
28.9
0.19
390
3786
(3045683) HLA typing for celiac disease panel - Blood or Tissue
7
38
1.85
0.74
1.0
1.0
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
139
1252
1.16
0.73
5.4
5.0
e6/l
45.3
56.0
0.18
89
845
(3026361) Erythrocytes [#/volume] in Blood
396
3862
1.28
0.73
18.0
14.8
e12/l
4.6
4.6
0.46
372
3663
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
5
25
2.01
0.73
1.6
1.9
mg/l
1.4
1.6
—
5
18
(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum
5
25
2.01
0.73
1.6
1.9
mg/l
1.4
7.6
—
5
18
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
5
25
2.01
0.73
1.6
1.9
mg/l
2.5
5.3
—
5
17
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
5
25
2.01
0.73
1.6
1.9
mg/l
0.5
1.1
—
5
19
(3045142) Bone marrow Pathology biopsy report
7
39
1.81
0.72
1.3
1.7
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
39
1.81
0.72
2.0
1.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
348
3353
1.19
0.72
9.3
7.6
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
191
1763
1.15
0.72
3.0
2.7
mmol/l
2.6
2.6
0.21
182
1648
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
24
177
1.38
0.72
2.7
2.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
22
160
1.39
0.71
1.5
1.6
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
7
40
1.76
0.71
2.0
1.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
7
40
1.76
0.71
6.6
9.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
9
57
1.59
0.71
1.3
1.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
128
1149
1.16
0.71
6.7
9.3
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
5
26
1.93
0.71
1.0
1.6
—
—
—
0
0
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
5
26
1.93
0.71
1.6
2.0
mg/l
1.4
1.0
—
5
19
(3002385) Erythrocyte distribution width [Ratio]
337
3241
1.17
0.70
17.4
14.3
%
13.3
13.1
1.98
329
3176
(3047007) Chlamydophila sp Ab [Presence] in Serum
9
146
0.61
0.70
1.2
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
21
284
0.73
0.70
1.0
1.2
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
7
41
1.72
0.70
9.7
10.7
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
9
58
1.56
0.70
2.6
2.5
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
396
3866
1.27
0.69
18.3
15.0
g/l
132.6
133.5
0.65
390
3796
(3010813) Leukocytes [#/volume] in Blood
396
3866
1.27
0.69
18.0
14.8
e9/l
6.8
6.7
0.12
373
3673
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
60
505
1.22
0.69
1.9
1.7
mmol/l
1.6
1.2
0.51
55
468
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
11
69
1.61
0.69
1.7
1.5
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
5
27
1.86
0.68
1.0
1.5
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
395
3856
1.26
0.68
18.1
14.9
e9/l
274.8
270.7
0.54
370
3673
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
167
1809
0.87
0.67
2.2
2.1
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
7
43
1.64
0.67
4.3
5.8
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
77
666
1.19
0.67
1.8
1.5
pmol/l
98.9
98.9
0.00
47
352
(3023410) Appearance of Cerebral spinal fluid
13
86
1.53
0.66
5.7
6.0
—
—
—
0
0
(1002224) Polysomnography panel
5
28
1.79
0.66
1.4
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
57
671
0.83
0.65
1.6
1.7
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
7
44
1.60
0.65
2.6
2.5
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
32
252
1.29
0.64
1.6
1.4
pmol/l
567.2
29911146.1
0.50
25
224
(3002032) Base excess in Venous blood by calculation
85
747
1.17
0.62
9.8
9.4
mmol/l
0.0
1.2
1.40
68
581
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
5
30
1.67
0.61
4.0
1.7
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
21
0.00
0.60
0.0
2.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
10
64
1.57
0.59
1.6
1.6
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
180
1674
1.13
0.58
2.9
2.6
mmol/l
1.2
1.1
0.82
172
1580
(4027681)
6
35
1.72
0.58
1.3
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
8
54
1.49
0.57
7.1
2.6
—
—
—
0
0
(21494434) Karyotype in Bone marrow
6
36
1.67
0.57
1.3
1.3
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
11
73
1.52
0.56
1.2
2.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
8
55
1.46
0.56
1.4
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
8
55
1.46
0.56
1.4
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
37
1.63
0.55
2.0
1.2
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
230
2177
1.12
0.54
10.1
10.4
e9/l
3.3
3.4
0.74
190
1821
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
6
38
1.59
0.54
8.3
7.1
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
6
38
1.59
0.54
8.3
6.8
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
39
324
1.22
0.53
1.3
2.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
23
179
1.30
0.52
1.7
1.7
nmol/l
1124.9
1102.0
0.04
17
134
(40760892) CBC W Ordered Manual Differential panel - Blood
79
701
1.15
0.52
5.4
5.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
16
213
0.74
0.51
1.2
1.8
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
11
75
1.48
0.51
2.9
4.9
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
16
118
1.37
0.50
1.1
1.4
u/ml
0.8
3.4
1.29
11
78
(3023323) Follitropin [Units/volume] in Serum or Plasma
33
271
1.23
0.50
2.0
2.4
iu/l
4.5
7.7
2.85
24
182
(3014148) Varicella zoster virus Ab [Titer] in Serum
7
107
0.65
0.49
1.0
1.2
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
213
2017
1.11
0.48
8.0
8.8
%
49.0
49.6
0.28
208
1927
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
68
1.48
0.47
2.6
1.5
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
38
320
1.20
0.46
5.3
5.0
e9/l
62.1
62.0
0.00
27
201
(3025018) Bordetella pertussis Ab [Titer] in Serum
8
119
0.67
0.46
1.3
1.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
167
1565
1.11
0.46
3.9
3.1
mmol/mol
36.6
36.3
0.12
158
1468
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
190
1794
1.10
0.45
3.1
2.8
mmol/l
4.3
4.3
0.04
182
1705
(3012516) Albumin [Mass/volume] in Urine
32
266
1.22
0.44
3.8
3.8
mg/l
57.3
93.5
0.50
26
212
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
6
95
0.63
0.42
1.0
1.0
mmol/l
18.5
19.2
—
6
95
(3006598) pH of Arterial cord blood
6
95
0.63
0.42
1.0
1.0
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
42
361
1.18
0.42
5.0
3.2
ng/l
1229.9
1407.8
0.08
18
202
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
23
282
0.80
0.42
1.4
1.3
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
0
15
0.00
0.41
0.0
2.6
—
3.8
—
0
15
(3032641) Amino acids panel - Urine
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
0
15
0.00
0.41
0.0
4.7
—
4.6
—
0
15
(3013727) Leukocytes other/100 leukocytes in Blood
0
16
0.00
0.41
0.0
6.4
—
44.3
—
0
16
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.1
—
1164.3
—
0
16
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
16
0.00
0.41
0.0
2.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
10
138
0.72
0.41
3.1
2.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
72
647
1.13
0.41
2.1
1.6
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
0
17
0.00
0.40
0.0
1.6
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
34
288
1.20
0.40
12.1
9.7
mmol/l
105.0
105.5
0.30
34
283
(3014765) Yersinia sp identified in Stool by Organism specific culture
7
101
0.69
0.40
1.3
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
7
102
0.68
0.40
1.3
1.2
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
216
2063
1.09
0.39
8.3
8.9
%
35.9
35.0
0.56
210
1966
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
19
0.00
0.39
0.0
5.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
16
124
1.30
0.39
1.3
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
16
124
1.30
0.39
1.3
1.4
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
11
80
1.38
0.38
1.5
2.0
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
36
1.39
0.38
1.8
1.3
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
5
36
1.39
0.38
1.0
1.6
%
168.8
118.1
—
5
36
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
36
1.39
0.38
1.0
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
12
89
1.36
0.38
1.4
2.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
184
1747
1.09
0.38
3.0
2.7
mmol/l
1.4
1.4
0.86
175
1646
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
13
98
1.34
0.37
2.3
4.4
%
26.0
26.1
0.02
13
98
(3026782) Osmolality of Urine
76
690
1.12
0.37
2.9
3.4
mosm/kgh2o
510.4
610.3
2.69
66
602
(3013336) Amino acids [Identifier] in Serum or Plasma
5
37
1.35
0.37
3.8
2.1
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
221
2117
1.09
0.37
4.3
4.4
mm/h
8.9
6.9
1.19
207
1968
(44813793)
9
70
1.29
0.37
1.0
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
6
41
1.47
0.36
1.0
1.2
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
13
99
1.32
0.35
1.2
1.2
iu/ml
199.8
314.4
—
6
28
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
6
42
1.43
0.35
1.8
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
6
42
1.43
0.35
3.5
1.5
—
—
—
0
0
(3019225) pH of Specimen
15
117
1.29
0.35
1.9
4.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
31
265
1.18
0.34
5.2
4.4
mg/mmol
6.0
9.0
0.33
25
215
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
30
256
1.18
0.34
3.0
1.8
mmol/l
2.4
2.4
0.28
25
210
(3001604) Monocytes [#/volume] in Blood
212
2033
1.08
0.34
8.1
9.0
e9/l
0.6
0.6
0.11
177
1698
(3000093) Morphology [Interpretation] in Blood Narrative
6
45
1.34
0.34
1.2
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
94
1012
0.91
0.33
1.8
1.5
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
85
783
1.11
0.33
14.9
12.9
mmol/l
24.7
24.7
0.01
85
783
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
6
89
0.67
0.33
1.2
1.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
72
658
1.11
0.32
5.9
4.3
inr
1.1
1.1
0.75
24
197
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
12
92
1.31
0.32
1.2
1.2
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
41
362
1.15
0.31
2.7
2.3
u/l
16801.8
7894.1
—
6
108
(3006504) Eosinophils/100 leukocytes in Blood
205
1968
1.08
0.31
8.5
9.1
%
2.9
3.2
0.88
200
1869
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
7
96
0.72
0.31
1.3
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
7
53
1.33
0.31
32.1
20.0
%
11.7
11.7
—
7
53
(3036481) Cortisol [Moles/volume] in Serum or Plasma
49
439
1.13
0.31
2.2
2.7
nmol/l
374.0
351.1
0.34
44
420
(3045414) Leukocytes [Presence] in Urine
7
100
0.69
0.31
3.4
1.6
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
50
449
1.13
0.30
1.2
1.7
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
10
75
1.34
0.30
1.1
1.2
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
217
2090
1.08
0.30
8.0
8.9
e9/l
2.3
2.3
0.16
187
1798
(3006245) CD3-CD19+ cells/100 cells in Blood
14
111
1.27
0.30
2.4
4.6
%
16.9
17.7
0.08
14
111
(3037467) Urinalysis macro (dipstick) panel - Urine
200
1921
1.08
0.30
4.6
4.0
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
11
141
0.77
0.30
1.1
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
22
185
1.20
0.29
1.2
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
7
56
1.25
0.29
6.3
4.6
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
157
1496
1.08
0.29
3.7
4.3
u/l
27.5
26.2
0.20
144
1438
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
35
396
0.87
0.29
1.1
1.2
—
3.3
—
0
5
(3037522) Nuclear Ab [Titer] in Serum
40
448
0.88
0.28
1.6
1.6
titre
592.0
524.4
—
5
72
(3021879) Hepatitis B virus core Ab [Presence] in Serum
30
261
1.16
0.28
1.7
1.4
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
25
290
0.85
0.28
1.6
1.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
27
311
0.86
0.28
4.4
1.9
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
12
94
1.28
0.28
1.2
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
60
548
1.11
0.28
2.3
1.8
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
206
1985
1.07
0.28
8.9
9.2
%
8.4
8.3
0.33
201
1885
(3009542) Hematocrit [Volume Fraction] of Blood
356
3499
1.09
0.27
16.4
13.1
%
39.3
39.4
0.26
307
3077
(3006315) Basophils [#/volume] in Blood
211
2037
1.07
0.27
8.1
9.0
e9/l
0.0
0.0
1.09
177
1702
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
13
104
1.26
0.26
2.3
4.4
%
10.2
8.1
0.72
13
99
(1175426) CD3 cells/100 lymphocytes in Blood
13
104
1.26
0.26
2.3
4.4
%
67.6
68.0
0.04
13
104
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
21
178
1.19
0.26
1.4
1.3
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
5
72
0.69
0.26
1.0
1.2
—
4.0
—
0
6
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
5
73
0.68
0.26
1.0
1.2
—
14.9
—
0
8
(3014007) Fractional oxyhemoglobin in Arterial blood
15
123
1.23
0.25
12.1
14.0
%
93.0
95.7
0.34
15
123
(36660697) Celiac disease serology panel - Serum
59
640
0.91
0.25
1.3
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
9
75
1.20
0.25
2.6
5.6
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
12
148
0.81
0.25
8.2
5.8
ng/l
111.8
177.5
0.54
12
139
(3026008) Bacteria identified in Urine by Culture
79
737
1.09
0.25
3.0
2.3
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
11
87
1.27
0.24
2.8
5.9
%
92.9
93.8
0.04
11
87
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
6
82
0.73
0.24
1.2
1.6
ug/l
2.8
6.2
—
6
77
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
197
1904
1.06
0.23
2.5
2.2
mmol/l
5.5
5.3
0.72
175
1728
(3047181) Lactate [Moles/volume] in Blood
5
39
1.28
0.23
10.8
2.6
mmol/l
1.1
1.3
—
5
32
(3035320) C reactive protein [Mass/volume] in Body fluid
5
39
1.28
0.23
1.0
1.9
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
174
1677
1.06
0.23
3.9
3.3
ug/l
57.7
46.5
0.39
165
1587
(3035933) Granulocytes/100 leukocytes in Blood
7
94
0.74
0.22
1.6
1.4
—
—
—
0
0
(3013512) EKG study
42
382
1.11
0.22
2.5
2.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
10
124
0.80
0.22
1.0
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
42
1.19
0.21
3.0
1.4
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
5
42
1.19
0.21
4.2
3.0
umol/l
62.2
56.5
—
5
42
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
5
42
1.19
0.21
3.6
2.8
u/ml
35.0
54.0
—
5
34
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.2
—
171.3
—
0
10
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
0
10
0.00
0.21
0.0
17.0
—
—
—
0
0
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
17.1
—
26.4
—
0
10
(3010503) CD19 cells [#/volume] in Blood
0
10
0.00
0.21
0.0
2.7
—
0.3
—
0
10
(3034426) Prothrombin time (PT)
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
0
11
0.00
0.21
0.0
1.4
—
10311.8
—
0
6
(3045788) Cell count panel - Pleural fluid
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
15
126
1.20
0.21
14.5
9.0
mmol/l
22.6
23.1
0.34
15
115
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.1
—
1.0
—
0
5
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
48
1.25
0.20
1.2
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
6
48
1.25
0.20
1.0
5.2
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
6
48
1.25
0.20
1.0
5.2
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
0
14
0.00
0.20
0.0
2.7
—
106.6
—
0
14
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
14
0.00
0.20
0.0
2.7
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
14
0.00
0.20
0.0
1.9
—
—
—
0
0
(4211845)
0
14
0.00
0.20
0.0
1.9
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
9
111
0.81
0.20
2.1
1.6
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
13
108
1.21
0.20
13.2
12.5
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
16
186
0.85
0.19
1.2
1.1
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
29
260
1.12
0.19
3.5
2.4
u/l
27.6
30.8
0.43
24
211
(3051651) Icteric interference index of Serum or Plasma
6
51
1.18
0.19
7.0
4.8
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
41
376
1.10
0.19
7.0
7.2
umol/l
4.8
6.5
0.95
35
313
(3013290) Carbon dioxide [Partial pressure] in Blood
7
58
1.21
0.18
3.3
8.0
kpa
5.7
4.8
—
7
58
(3027315) Oxygen [Partial pressure] in Blood
7
58
1.21
0.18
3.4
8.0
kpa
8.0
9.2
—
7
58
(3044640) Blood type and Crossmatch panel - Blood
74
780
0.94
0.17
4.0
3.4
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
170
1650
1.05
0.17
9.5
6.5
mmol/l
6.2
6.0
0.32
162
1540
(3014051) Protein [Presence] in Urine by Test strip
5
69
0.72
0.17
4.2
1.7
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
52
486
1.08
0.17
1.3
1.7
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
55
585
0.93
0.16
2.3
2.1
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
11
92
1.20
0.16
1.5
1.7
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
214
2091
1.05
0.16
9.1
9.6
e9/l
0.2
0.2
0.97
184
1792
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
8
73
1.10
0.15
1.4
1.3
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
8
73
1.10
0.15
1.4
1.3
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
8
73
1.10
0.15
1.4
1.3
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
8
73
1.10
0.15
1.4
1.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
109
1048
1.05
0.15
1.8
1.8
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
22
197
1.12
0.15
1.2
1.1
u/ml
12.4
6.6
0.53
14
110
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
44
410
1.08
0.15
1.3
1.4
%
1.3
1.4
0.09
38
373
(4062490)
9
78
1.16
0.15
1.3
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
64
675
0.94
0.15
2.5
2.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
9
81
1.11
0.15
1.0
1.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
9
82
1.10
0.15
4.1
4.4
%
43.8
50.9
—
9
82
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
20
223
0.89
0.15
1.9
2.0
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
26
237
1.10
0.14
1.7
2.2
nmol/l
12.8
9.0
0.53
19
183
(3015076) Soybean IgE Ab [Units/volume] in Serum
10
84
1.19
0.14
1.2
1.1
u/ml
0.4
1.6
—
5
23
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
255
2508
1.04
0.13
3.9
3.2
pmol/l
14.3
14.4
0.10
230
2236
(3052851) Hemolysis interference index of Serum or Plasma
9
109
0.82
0.13
5.6
3.7
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
12
104
1.16
0.12
2.3
4.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
51
483
1.06
0.12
1.3
1.7
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
18
162
1.12
0.12
1.1
1.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
69
661
1.05
0.11
3.8
3.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
46
435
1.06
0.11
3.2
2.4
ng/l
20.7
16.3
0.26
13
148
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
278
2814
0.97
0.11
4.3
3.6
mu/l
2.0
2.0
0.12
258
2638
(3007853) Bacteria identified in Skin by Aerobe culture
42
444
0.94
0.11
2.5
1.7
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
12
105
1.15
0.11
1.3
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
12
136
0.88
0.11
1.1
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
51
486
1.06
0.10
1.3
1.7
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
14
125
1.12
0.10
12.5
13.8
%
0.7
0.7
0.11
14
125
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
30
281
1.07
0.09
2.1
1.9
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
139
1419
0.97
0.09
1.6
1.7
g/l
1.5
1.5
0.24
74
721
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
106
1033
1.03
0.09
2.8
2.6
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
31
292
1.07
0.09
8.5
6.8
ng/l
2277.1
703.7
0.73
25
245
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
60
0.83
0.08
2.2
2.5
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
5
65
0.77
0.08
1.0
1.4
—
184.0
—
0
15
(3016018) Differential panel - Cerebral spinal fluid
7
64
1.09
0.08
5.6
4.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
13
117
1.11
0.08
1.8
1.3
—
—
—
0
0
(3010421) pH of Blood
7
65
1.08
0.08
3.4
7.3
ph
7.4
7.4
—
7
58
(3019832) Treponema pallidum Ab [Presence] in Serum
56
580
0.96
0.07
2.2
1.8
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
179
1815
0.98
0.07
10.4
6.2
ml/min/173m2
110.8
112.1
0.26
117
1149
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
7
82
0.85
0.07
1.6
1.5
—
—
—
0
0
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
8
91
0.88
0.07
2.4
2.1
nmol/l
0.2
0.1
—
8
73
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
10
89
1.13
0.07
1.3
1.7
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
8
95
0.84
0.06
1.8
1.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
9
105
0.85
0.06
3.2
2.1
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
50
483
1.04
0.06
1.3
1.7
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
33
345
0.95
0.06
1.2
1.2
u/ml
2.1
10.2
—
10
103
(3035637) Corticotropin [Mass/volume] in Plasma
16
148
1.08
0.06
1.6
1.8
—
—
—
0
0
(3044889) 12 lead EKG panel
133
1308
1.02
0.06
2.3
2.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
47
486
0.96
0.06
1.1
1.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
14
151
0.92
0.05
1.7
1.9
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
30
313
0.95
0.05
1.3
1.2
u/ml
3.0
3.0
0.01
13
102
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
11
100
1.10
0.05
2.2
1.8
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
16
171
0.93
0.05
1.2
1.1
u/ml
1.1
0.7
—
8
74
(3000850) Epithelial cells [#/volume] in Urine
73
715
1.02
0.04
3.9
3.4
e6/l
7.6
7.3
0.07
64
634
(3003888) Timothy IgE Ab [Units/volume] in Serum
34
328
1.04
0.04
1.2
1.2
u/ml
8.2
7.2
0.11
25
245
(3023430) Cat dander IgE Ab [Units/volume] in Serum
19
180
1.06
0.04
1.2
1.1
u/ml
26.5
10.1
0.37
12
108
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
16
151
1.06
0.03
1.3
1.4
g/l
0.2
0.2
0.42
16
145
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
21
201
1.05
0.03
1.3
1.4
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
16
152
1.05
0.02
1.3
1.4
g/l
1.2
1.1
0.31
16
145
(1001926) Buprenorphine [Presence] in Urine by Screen method
39
381
1.03
0.02
1.3
1.7
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
33
322
1.03
0.01
1.2
1.2
u/ml
0.5
1.1
1.28
24
230
(3048689) Calprotectin [Mass/mass] in Stool
75
741
1.01
0.01
2.4
3.3
ug/g
78.5
112.8
0.81
59
577
(3018677) aPTT in Platelet poor plasma by Coagulation assay
52
527
0.98
0.01
8.8
6.1
s
32.6
31.0
0.81
52
520
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
99
984
1.01
0.00
2.7
2.4
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
17
167
1.02
0.00
1.4
1.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
21
206
1.02
0.00
1.9
1.7
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
22
218
1.01
0.00
1.3
1.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
363
3632
0.99
0.00
4.0
3.9
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
35
348
1.01
0.00
1.3
1.3
u/ml
2.9
3.0
0.02
24
225
(3028707) Methadone [Presence] in Urine by Screen method
23
228
1.01
0.00
1.2
2.0
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
13
133
0.98
0.00
1.5
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
18
184
0.98
0.00
1.0
1.0
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
12
115
1.04
0.00
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
12
116
1.03
0.00
1.0
1.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
14
143
0.98
0.00
1.4
1.3
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
96
959
1.00
0.00
2.4
2.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
37
373
0.99
0.00
1.2
1.2
iu/ml
8.8
14.9
—
6
82
(40768797) Stomach Pathology biopsy report
25
251
1.00
0.00
1.5
1.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
35
355
0.98
0.00
1.7
1.2
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
7.8
—
3.5
—
0
9
(3006442) Creatine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3012565) Volume of 24 hour Urine
0
8
0.00
0.00
0.0
1.3
—
1737.5
—
0
8
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
8
80
1.00
0.00
1.3
1.8
ng/l
211.5
139.7
—
8
75
(3038702) Sodium [Moles/volume] in Capillary blood
0
9
0.00
0.00
0.0
5.1
—
138.3
—
0
9
(3001019) Free T4 and TSH panel - Serum or Plasma
7
76
0.92
0.00
1.0
1.3
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
7
73
0.96
0.00
7.4
6.0
ug/l
2.0
2.1
—
7
73
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
8
86
0.93
0.00
9.1
3.1
ug/l
611.3
335.9
—
8
76
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(4146454)
0
7
0.00
0.00
0.0
3.4
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
1.0
—
85.6
—
0
5
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
6
65
0.92
0.00
1.0
1.2
%
100.8
79.4
—
6
65
(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine
0
5
0.00
0.00
0.0
1.0
—
305.0
—
0
5
(3002481) Calcium/Creatinine [Mass Ratio] in Urine
0
5
0.00
0.00
0.0
3.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
7
73
0.96
0.00
2.6
1.9
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768443) Skin Pathology biopsy report
7
72
0.97
0.00
1.4
1.1
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
7
78
0.90
0.00
5.1
7.8
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40760512) CD34 cells/100 cells in Bone marrow
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
6
62
0.97
0.00
1.0
1.6
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
6
64
0.94
0.00
1.0
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
57
0.88
0.00
1.0
1.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
8
85
0.94
0.00
1.6
1.3
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
8
81
0.99
0.00
4.1
4.0
e9/l
2.6
3.3
—
8
81
(3007463) Buprenorphine [Presence] in Urine
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
9
90
1.00
0.00
1.3
1.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
6
62
0.97
0.00
2.8
2.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(4198724)
6
66
0.91
0.00
1.5
1.6
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
8
79
1.01
0.00
2.0
3.6
—
717.3
—
0
6
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
7
73
0.96
0.00
1.0
1.5
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
0
5
0.00
0.00
0.0
4.0
—
—
—
0
0
(40763791) Oxygen content in Venous blood by calculation
0
6
0.00
-0.00
0.0
22.0
—
13.6
—
0
6
(3043410) Blood group antigens tested for on Red Blood Cells
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
6
0.00
-0.00
0.0
20.0
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
0
6
0.00
-0.00
0.0
1.5
—
75.1
—
0
6
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
0
6
0.00
-0.00
0.0
3.5
—
13.2
—
0
6
(3044242) Glucose [Moles/volume] in Arterial blood
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
0
6
0.00
-0.00
0.0
3.5
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint P16_INFECTIONS_SPECIFIC_PERINA_PERIOD and mortality.

Females

Parameter HR [95% CI] p-value
P16_INFECTIONS_SPECIFIC_PERINA_PERIOD 1.84 [1.45, 2.34] < 0.001
Birth year 0.998 [0.99, 1.01] 0.613

During the follow-up period (1.1.1998 — 31.12.2019), 79 out of 16734 females with P16_INFECTIONS_SPECIFIC_PERINA_PERIOD died.

Males

Parameter HR [95% CI] p-value
P16_INFECTIONS_SPECIFIC_PERINA_PERIOD 1.099 [0.9, 1.34] 0.351
Birth year 0.987 [0.98, 1.0] 0.01

During the follow-up period (1.1.1998 — 31.12.2019), 113 out of 23642 males with P16_INFECTIONS_SPECIFIC_PERINA_PERIOD died.

Mortality risk

Mortality risk for people of age

years, who have P16_INFECTIONS_SPECIFIC_PERINA_PERIOD.

N-year risk Females Males
1 0.158% 0.199%
5 1.081% 1.32%
10 2.695% 3.159%
15 5.399% 6.062%
20 9.582% 10.507%

Relationships between endpoints

↥

Index endpoint: P16_INFECTIONS_SPECIFIC_PERINA_PERIOD – Infections specific to the perinatal period

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data